Similar articles

• Metabolic importance of acanthosis nigricans.

  Flier JS. Flier JS. Arch Dermatol. 1985 Feb;121(2):193-4. Arch Dermatol. 1985. PMID: 3977332 No abstract available.
• Polypeptide hormones: pathology and clinical aspects.

  Van Obberghen E. Van Obberghen E. Acta Histochem Suppl. 1984;29:51-5. Acta Histochem Suppl. 1984. PMID: 6425926 Review. No abstract available.
• [Insulin resistant diabetes, acanthosis nigricans and Bartter's syndrome, a fortuitous association?].

  Puel O, Massicot P, Taieb A, Seguin G, Foussier G, Guillard JM. Puel O, et al. Arch Fr Pediatr. 1992 Apr;49(4):361-3. Arch Fr Pediatr. 1992. PMID: 1497426 French.
• Insulin-resistant diabetes mellitus and insulin receptor antibodies: variable association with acanthosis nigricans.

  Goldman J. Goldman J. Henry Ford Hosp Med J. 1980;28(2-3):161-7. Henry Ford Hosp Med J. 1980. PMID: 7287512 No abstract available.
• [Physiologic and physiopathologic implications of insulin-receptor interaction (III)].

  Durán García S, González Mateo MC. Durán García S, et al. Med Clin (Barc). 1984 May 5;82(17):771-6. Med Clin (Barc). 1984. PMID: 6429461 Review. Spanish. No abstract available.